| Title |
Effect of Initial Prednisone Dosing on Ocular Myasthenia Gravis Control |
| Creator |
Yesha S. Shah, BBA, BSA; Amanda D. Henderson, MD; Andrew R. Carey, MD |
| Affiliation |
Johns Hopkins University School of Medicine (YSS), Baltimore, Maryland; and Division of Neuro-Ophthalmology (ADH, ARC), Department of Ophthalmology, Johns Hopkins University School of Medicine, Wilmer Eye Institute, Baltimore, Maryland |
| Abstract |
Ocular myasthenia is an autoimmune condition that results in double vision or ptosis. It often requires treatment with prednisone for immunosuppression, but there have been no prospective trials to help clinicians determine ideal dosing. |
| Subject |
Myasthenia Gravis; Ocular Myasthenia; Autoimmune |
| Date |
2021-12 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Publication Type |
Journal Article |
| Source |
Journal of Neuro-Ophthalmology, December 2021, Volume 41, Issue 4 |
| Collection |
Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/ |
| Publisher |
Lippincott, Williams & Wilkins |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
© North American Neuro-Ophthalmology Society |
| ARK |
ark:/87278/s6re5j0y |
| Setname |
ehsl_novel_jno |
| ID |
2116159 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6re5j0y |
